Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes

FEBS Letters

Volumn 390, Issue 1, 1996, Pages 109-112

  Rasmussen, Poul B ^a   Bjørn, Søren ^a   Hastrup, Sven ^a   Nielsen, Per F ^a   Norris, Kjeld ^a   Thim, Lars ^a   Wiberg, Finn C ^a   Flodgaard, Hans ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Baculovirus; Cytokine; HBP CAP37 azurocidin; Lipopolysaccharide; Mass spectrometry; N terminal processing

Indexed keywords

CYTOKINE; HEPARIN BINDING PROTEIN; LIPOPOLYSACCHARIDE; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; INFLAMMATION; MASS SPECTROMETRY; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

EID: 0030586281     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)00639-4     Document Type: Article

References (23)

1. [1] Pereira, H.A., Shafer, W.M., Pohl, J., Martin, L.E. and Spitznagel, J.K. (1990) J. Clin. Invest. 85, 1468-1476.
2. [2] Gabay, J.E., Scott, R.W., Campanelli, D., Griffith, J., Wilde, C., Marra, M.N., Seeger, M. and Nathan, C.F. (1989) Proc. Natl. Acad. Sci. USA 86, 5610-5614.
3. [3] Flodgaard, H., Ostergaard, E., Bayne, S., Svendsen, A., Thomsen, J., Engels, M. and Wollmer, A. (1991) Eur. J. Biochem. 197, 535-547.
4. [4] Pohl, J., Pereira, H.A., Martin, N.M. and Spitznagel, J.K. (1990) FEBS Lett. 272, 200-204.
5. [5] Pereira, H.A., Erdem, I., Pohl, J. and Spitznagel, J.K. (1993) Proc. Natl. Acad. Sci. USA 90, 4733-4737.
6. [6] Ostergaard, E. and Flodgaard, H. (1992) J. Leucoc. Biol. 51, 316-323.
7. [7] Pereira, H.A. (1995) J. Leucoc. Biol. 57, 805-812.
8. [8] Morgan, J.G., Sukiennicki, T., Pereira, H.A., Spitznagel, J.K., Guerra, M.E. and Larrick, J.W. (1991) J. Immunol. 147, 3210-3214.
9. [9] Almeida, R.P., Melchior, M., Campanelli, D., Nathan, C.F. and Gabay, J.E. (1991) Biochem. Biophys. Res. Commun. 177, 688-695.
10. [10] Malitschek, B. and Schartl, M. (1991) BioTechniques 11, 177-178.
11. [11] Webb, A.C., Bradley, M.K., Phelan, S.A., Wu, J.Q. and Gehrke, L. (1991) BioTechniques 11, 512-519.
12. [12] Falk, W., Goodwin, R.H. and Leonard, E.J. (1980) J. Immunol. Met. 33, 239-247.
13. [13] Nielsen, H and Larsen, S. O. (1983) Acta Path. Microbiol. Immunol. Scan. 91, 109-115.
14. [14] Böyum, A. (1968) Scand. J. Clin. Invest. 21, Suppl. 97, 77-89.
15. [15] Giddings, J.C., Piovella, F., Ricetti, M., Jarvis, A., Peake, I.R. and Bloom, A.L. (1980) Clin. Lab. Haemat. 2, 121-128.
16. [16] Kuroda, K., Geyer, H., Geyer, R., Doerfler, W. and Klenk, H.-D. (1990) Virology 174, 418-429.
17. [17] Tobias, P.S., Soldau, K. and Ulevitch, R.J. (1986) J. Exp. Med. 164, 777-793.
18. [18] Schumann, R.R., Leong, S.R., Flaggs, G.W., Gray, P.W., Wright, S.D., Mathison, J.C., Tobias, P.S. and Ulevitch, R.J. (1990) Science 249, 1429-1431.
19. [19] Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. and Mathison, J.C. (1990) Science 249, 1431-1433.
20. [20] Mathison, J.C., Tobias, P.S., Wolfson, E. and Ulevitch, R.J. (1992) J. Immunol. 149, 200-206.
21. [21] Martin, T.R., Mathison, J.C., Tobias, P.S., Maunder, R.J. and Ulevitch, R.J. (1992) J. Clin. Invest. 90, 2209-2219.
22. [22] Castell, J.V., Gomez-Lechon, M.J., David, M., Hirano, T., Kishmoto, T. and Heinrich, P. (1988) FEBS Lett. 232, 347-350.
23. [23] Castell, J.V., Gomez-Lechon, M.J., David, M., Andus, T., Geiger, T. and Trullenque, R. (1989) FEBS Lett. 242, 237-239.